Cohen’s kappa scores for intercoder reliability (79/368 recoded=21.5%)
| Practitioner | 0.8665 |
| Modes of stem cell therapy offered | 0.9672 |
| Advertised stem cell treatment targets | 0.9009 |
| Other treatments offered that reference stem cells | 0.9268 |
| States evidence of inefficacy | 1.0000 |
| States that there is limited evidence of efficacy | 1.0000 |
| States general risks | 1.0000 |
| States risks specific to mode of therapy | 1.0000 |
| States regulatory status | 0.9617 |
| States therapy is experimental or unproven | 0.9660 |
| Uses hype language | 1.0000 |